Trader Edge / parameter - Hims & Hers (HIMS) stock surged 44% premarket as Novo Nordisk plans to sell weight-loss drugs on its platform, resolving their legal battle.The post Hims & Hers (HIMS) Stock Rockets 44% on Surprise Novo Nordisk Partnership Deal appeared first on Parameter.
Back to Top / Monday, March 9, 2026, 10:21 am / permalink 20382 / 3 stories in 5 hrs
Lilly’s obesity pill data stirs conflicting market reactions / 7 months
CDC panel drops longstanding newborn hepatitis B shot policy / 3 months
UK healthtech Nul raises seed funding to scale supported alcohol-reduction platform / 21 days
Gilead to acquire Arcellx for $7.8 billion in cash deal / 14 days
German Recare Successfully Secures €37M Funding Round to Accelerate AI-Driven Hospital Solutions / 5 wks
Delaware Supreme Court Restores Musk’s $56B Pay Package / 2 months
Vaccine panel rejects COVID shot prescription requirement / 5 months
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.